Pub Date : 2024-01-01DOI: 10.17116/oftalma202414004186
M S Sergeeva, S S Danilov, N I Sherbakova
Myasthenia gravis is an autoimmune disease characterized by muscle weakness and pathological fatigue due to autoaggressive phenomena with the formation of antibodies directed against various structures of the neuromuscular synapse. In most patients, the disease begins with the involvement of extraocular muscles, presenting with symptoms such as intermittent ptosis of the upper eyelid and/or binocular diplopia. In 15% of cases, clinical manifestations are limited to impairment of the levator palpebrae superioris and extraocular muscles, characteristic of the ocular form of myasthenia gravis. Specialists often encounter challenges in diagnosing this form, as serological and electrophysiological studies may be uninformative, necessitating diagnosis based on patient history and clinical picture. This literature review outlines the key aspects of the pathogenesis, clinical manifestations, methods of diagnosis and treatment of ocular myasthenia gravis.
{"title":"[Ocular myasthenia gravis].","authors":"M S Sergeeva, S S Danilov, N I Sherbakova","doi":"10.17116/oftalma202414004186","DOIUrl":"https://doi.org/10.17116/oftalma202414004186","url":null,"abstract":"<p><p>Myasthenia gravis is an autoimmune disease characterized by muscle weakness and pathological fatigue due to autoaggressive phenomena with the formation of antibodies directed against various structures of the neuromuscular synapse. In most patients, the disease begins with the involvement of extraocular muscles, presenting with symptoms such as intermittent ptosis of the upper eyelid and/or binocular diplopia. In 15% of cases, clinical manifestations are limited to impairment of the levator palpebrae superioris and extraocular muscles, characteristic of the ocular form of myasthenia gravis. Specialists often encounter challenges in diagnosing this form, as serological and electrophysiological studies may be uninformative, necessitating diagnosis based on patient history and clinical picture. This literature review outlines the key aspects of the pathogenesis, clinical manifestations, methods of diagnosis and treatment of ocular myasthenia gravis.</p>","PeriodicalId":23529,"journal":{"name":"Vestnik oftalmologii","volume":"140 4","pages":"86-91"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142296632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01DOI: 10.17116/oftalma202414001132
M A Kashchenko, T P Kashchenko, M D Magaramova, E K Pedanova, S E Golyakhovskiy
Purpose: This study assesses the effect of pleoptic treatment on the stability of visual fixation in children and adolescents with amblyopia of various degrees.
Material and methods: The effect of the treatment in 35 children (35 eyes) with amblyopia of various degrees was evaluated using the MP-1 Microperimeter. The stability was determined by two criteria - number of fixation point hits in the 2° zone and the width of the field of fixation. Children underwent a standard course of treatment.
Results: There was an improvement in the stability of visual fixation after treatment. The number of fixation point hits in the 2° zone increased from 44.8±4.1% to 52.6±3.8%. At the same time, the width of the field of fixation after treatment decreased from 6.5±0.7° to 5.2±0.5°. Visual acuity with correction in children with amblyopia correlates with the number of fixation point hits in the 2° zone (direct high correlation "+0.7") and width of the field of fixation (inverse high correlation "-0.7") both before and after the treatment.
Conclusion: Stabilization of visual fixation was observed in patients with amblyopia of varying degrees after the pleoptic treatment.
{"title":"[The effect of pleoptic treatment on the stability of visual fixation in children and adolescents with amblyopia of various degrees].","authors":"M A Kashchenko, T P Kashchenko, M D Magaramova, E K Pedanova, S E Golyakhovskiy","doi":"10.17116/oftalma202414001132","DOIUrl":"10.17116/oftalma202414001132","url":null,"abstract":"<p><strong>Purpose: </strong>This study assesses the effect of pleoptic treatment on the stability of visual fixation in children and adolescents with amblyopia of various degrees.</p><p><strong>Material and methods: </strong>The effect of the treatment in 35 children (35 eyes) with amblyopia of various degrees was evaluated using the MP-1 Microperimeter. The stability was determined by two criteria - number of fixation point hits in the 2° zone and the width of the field of fixation. Children underwent a standard course of treatment.</p><p><strong>Results: </strong>There was an improvement in the stability of visual fixation after treatment. The number of fixation point hits in the 2° zone increased from 44.8±4.1% to 52.6±3.8%. At the same time, the width of the field of fixation after treatment decreased from 6.5±0.7° to 5.2±0.5°. Visual acuity with correction in children with amblyopia correlates with the number of fixation point hits in the 2° zone (direct high correlation \"+0.7\") and width of the field of fixation (inverse high correlation \"-0.7\") both before and after the treatment.</p><p><strong>Conclusion: </strong>Stabilization of visual fixation was observed in patients with amblyopia of varying degrees after the pleoptic treatment.</p>","PeriodicalId":23529,"journal":{"name":"Vestnik oftalmologii","volume":"140 1","pages":"32-35"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140050403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01DOI: 10.17116/oftalma202414001165
Yu N Yusef, S N Yusef, A S Vvedenskiy, A A Gamidov, M N Ivanov, K S Avetisov, K Alkhumidi
Prevention and treatment of anterior capsular contraction syndrome (ACCS) is a relevant problem in cataract surgery.
Purpose: The study was performed to develop a femtosecond laser-assisted technique for anterior capsulotomy in anterior capsular contraction syndrome and assess its preliminary results in preventing the progression of pathological changes in the capsular bag.
Material and methods: The examination and femtosecond laser-assisted treatment without additional surgical intervention was performed in 6 patients (6 eyes) aged 69 to 73 years with anterior capsular contraction syndrome. Femtosecond laser-assisted anterior capsulotomy was performed using the VICTUS system (Technolas Perfect Vision, Germany). Capsulotomy diameter was 4.0-4.5 mm, laser radiation energy - 9000 nJ, laser exposure depth 900-1000 μm.
Results: The diameter of the anterior capsulotomy before treatment was 2.85 mm [2.75; 2.93]. After 1 month, the diameter of the anterior capsular opening was 2.88 mm [2.78; 2.96] (p>0.05). One year after femtosecond laser intervention, the anterior capsulotomy opening was almost the same shape and diameter - 2.84 mm [2.74; 2.94] (p>0.05).
Conclusion: Femtosecond laser-assisted circular capsulotomy is an effective and safe method for preventing the progression of anterior capsular contraction syndrome in the absence of severe IOL decentration and for maintaining the diameter of the anterior capsular opening of at least 2.5-3.0 mm.
目的:该研究旨在开发一种飞秒激光辅助的前囊切开术治疗前囊收缩综合征,并评估其在防止囊袋病理变化进展方面的初步效果:对6名年龄在69至73岁之间的前囊收缩综合征患者(6只眼)进行了检查和飞秒激光辅助治疗,无额外手术干预。飞秒激光辅助前囊切开术是使用 VICTUS 系统(德国 Technolas Perfect Vision 公司)进行的。囊肿切除直径为 4.0-4.5 mm,激光辐射能量为 9000 nJ,激光照射深度为 900-1000 μm:结果:治疗前的前囊切直径为 2.85 mm [2.75; 2.93]。一个月后,前囊口直径为 2.88 mm [2.78; 2.96] (p>0.05)。飞秒激光介入治疗一年后,前囊开口的形状和直径几乎保持不变--2.84 毫米 [2.74; 2.94] (P>0.05):飞秒激光辅助环形囊切开术是一种有效、安全的方法,可在无严重人工晶体脱位的情况下防止前囊收缩综合征的发展,并将前囊开口直径维持在至少2.5-3.0毫米。
{"title":"[The first experience of using femtosecond laser in the treatment of anterior capsular contraction syndrome].","authors":"Yu N Yusef, S N Yusef, A S Vvedenskiy, A A Gamidov, M N Ivanov, K S Avetisov, K Alkhumidi","doi":"10.17116/oftalma202414001165","DOIUrl":"10.17116/oftalma202414001165","url":null,"abstract":"<p><p>Prevention and treatment of anterior capsular contraction syndrome (ACCS) is a relevant problem in cataract surgery.</p><p><strong>Purpose: </strong>The study was performed to develop a femtosecond laser-assisted technique for anterior capsulotomy in anterior capsular contraction syndrome and assess its preliminary results in preventing the progression of pathological changes in the capsular bag.</p><p><strong>Material and methods: </strong>The examination and femtosecond laser-assisted treatment without additional surgical intervention was performed in 6 patients (6 eyes) aged 69 to 73 years with anterior capsular contraction syndrome. Femtosecond laser-assisted anterior capsulotomy was performed using the VICTUS system (Technolas Perfect Vision, Germany). Capsulotomy diameter was 4.0-4.5 mm, laser radiation energy - 9000 nJ, laser exposure depth 900-1000 μm.</p><p><strong>Results: </strong>The diameter of the anterior capsulotomy before treatment was 2.85 mm [2.75; 2.93]. After 1 month, the diameter of the anterior capsular opening was 2.88 mm [2.78; 2.96] (<i>p</i>>0.05). One year after femtosecond laser intervention, the anterior capsulotomy opening was almost the same shape and diameter - 2.84 mm [2.74; 2.94] (<i>p</i>>0.05).</p><p><strong>Conclusion: </strong>Femtosecond laser-assisted circular capsulotomy is an effective and safe method for preventing the progression of anterior capsular contraction syndrome in the absence of severe IOL decentration and for maintaining the diameter of the anterior capsular opening of at least 2.5-3.0 mm.</p>","PeriodicalId":23529,"journal":{"name":"Vestnik oftalmologii","volume":"140 1","pages":"65-70"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140050404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01DOI: 10.17116/oftalma202414001158
V V Brzheskiy, E A Drozdova, V A Bobryshev, E V Berdnikova, S Yu Golubev
In recent years, among artificial tear preparations that have additional metabolic properties, in addition to moisturizing the ocular surface, there has been a drug Optinol Soft Recovery (LLC JADRAN). In addition to 0.15% sodium hyaluronate, it contains 2% dexpanthenol, which stimulates reparative regeneration of the corneal epithelium, in particular in patients with dry eye syndrome (DES).
Purpose: This study evaluates the clinical efficacy of the drug Optinol Soft Recovery in the treatment of patients with DES accompanied by xerotic changes in the corneal epithelium.
Material and methods: The study included 82 patients (15 children and 65 adults) with moderate and severe DES accompanied by the following corneal pathology: filamentous keratitis (20 patients, 33 eyes), persistent corneal erosion (28 patients, 49 eyes) and punctate keratopathy (34 patients, 68 eyes).
Results: All patients receiving fourfold instillations of the studied drug were observed already during the first 7 days to have increased stability of the tear film and decreased severity of staining of the cornea and conjunctiva with vital dyes (0.1% sodium fluorescein and 3% lissamine green, respectively). Further, as the patients were transferred to an individual instillation regimen, a progressive decrease in the Ocular Surface Disease Index (OSDI), an increase in corneal sensitivity and tear meniscus index were also recorded. The differences in most parameters of the course of xerosis compared to the initial ones were statistically significant starting from day 10-20 of therapy, depending on the initial severity of corneal xerosis (p<0.05-0.001).
Conclusion: Patients with moderate DES complicated by punctate keratopathy were the most susceptible to therapy with the drug Optinol Soft Recovery, while patients with filamentous keratitis secondary to a severe clinical form of DES were the least susceptible.
近年来,在具有额外代谢特性的人工泪液制剂中,除了滋润眼表之外,还有一种药物 Optinol Soft Recovery(LLC JADRAN)。除了 0.15%的透明质酸钠外,它还含有 2%dexpanthenol,能刺激角膜上皮的修复性再生,尤其适用于干眼症(DES)患者。目的:本研究评估了 Optinol Soft Recovery 药物在治疗伴有角膜上皮干燥性变化的 DES 患者中的临床疗效:研究对象包括82名患有中度和重度DES并伴有以下角膜病变的患者(15名儿童和65名成人):丝状角膜炎(20名患者,33只眼)、持续性角膜糜烂(28名患者,49只眼)和点状角膜病(34名患者,68只眼):所有接受四倍剂量药物注射的患者在最初的 7 天内都能观察到泪膜的稳定性增强,角膜和结膜被重要染料(分别为 0.1%荧光素钠和 3%立沙明绿)染色的严重程度降低。此外,随着患者转为个体化灌注方案,眼表疾病指数(OSDI)逐渐下降,角膜敏感度和泪液半月板指数也有所上升。根据角膜角化病的最初严重程度,从治疗的第 10-20 天开始,大部分角化病病程参数与最初参数相比都有显著的统计学差异(p 结论:中度 DES 并发点状角膜病变的患者最容易接受 Optinol Soft Recovery 药物治疗,而继发于严重临床形式 DES 的丝状角膜炎患者最不容易接受。
{"title":"[New possibilities for reparative therapy of dry eye syndrome].","authors":"V V Brzheskiy, E A Drozdova, V A Bobryshev, E V Berdnikova, S Yu Golubev","doi":"10.17116/oftalma202414001158","DOIUrl":"10.17116/oftalma202414001158","url":null,"abstract":"<p><p>In recent years, among artificial tear preparations that have additional metabolic properties, in addition to moisturizing the ocular surface, there has been a drug Optinol Soft Recovery (LLC JADRAN). In addition to 0.15% sodium hyaluronate, it contains 2% dexpanthenol, which stimulates reparative regeneration of the corneal epithelium, in particular in patients with dry eye syndrome (DES).</p><p><strong>Purpose: </strong>This study evaluates the clinical efficacy of the drug Optinol Soft Recovery in the treatment of patients with DES accompanied by xerotic changes in the corneal epithelium.</p><p><strong>Material and methods: </strong>The study included 82 patients (15 children and 65 adults) with moderate and severe DES accompanied by the following corneal pathology: filamentous keratitis (20 patients, 33 eyes), persistent corneal erosion (28 patients, 49 eyes) and punctate keratopathy (34 patients, 68 eyes).</p><p><strong>Results: </strong>All patients receiving fourfold instillations of the studied drug were observed already during the first 7 days to have increased stability of the tear film and decreased severity of staining of the cornea and conjunctiva with vital dyes (0.1% sodium fluorescein and 3% lissamine green, respectively). Further, as the patients were transferred to an individual instillation regimen, a progressive decrease in the Ocular Surface Disease Index (OSDI), an increase in corneal sensitivity and tear meniscus index were also recorded. The differences in most parameters of the course of xerosis compared to the initial ones were statistically significant starting from day 10-20 of therapy, depending on the initial severity of corneal xerosis (<i>p</i><0.05-0.001).</p><p><strong>Conclusion: </strong>Patients with moderate DES complicated by punctate keratopathy were the most susceptible to therapy with the drug Optinol Soft Recovery, while patients with filamentous keratitis secondary to a severe clinical form of DES were the least susceptible.</p>","PeriodicalId":23529,"journal":{"name":"Vestnik oftalmologii","volume":"140 1","pages":"58-64"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140050470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01DOI: 10.17116/oftalma2024140022190
L Alkharki, Yu N Yusef, M V Budzinskaya, K S Avetisov, A V Shitikova
Optical coherence tomography of the anterior segment of the eye (AS-OCT) is a non-invasive method based on the principles of optical reflectometry (measurement of the degree of backscattering of light passing through transparent or translucent media). Limitations of the first devices of this type were associated with insufficient image quality of the details of the anterior chamber angle and the posterior parts of the lens, primarily due to the "working" level of the scanning wavelength (within 800 μm). Fundamentally new possibilities in the structural and functional assessment of the anterior segment of the eye are associated with the introduction into clinical practice of swept-source AS-OCT device - the CASIA2 anterior optical coherence tomograph (Tomey Corporation, Japan). Its high scanning speed (50 000 A-scans per second) with a wavelength of 1310 μm allows high-quality visualization by building a scan at a depth of 13 mm. The previous model (CASIA SS-1000, Tomey Corporation, Japan) supported scan depth of only 6 mm. This review summarizes the results of research on the clinical use of CASIA2 tomograph.
{"title":"[Current capabilities of anterior segment optical coherence tomography].","authors":"L Alkharki, Yu N Yusef, M V Budzinskaya, K S Avetisov, A V Shitikova","doi":"10.17116/oftalma2024140022190","DOIUrl":"10.17116/oftalma2024140022190","url":null,"abstract":"<p><p>Optical coherence tomography of the anterior segment of the eye (AS-OCT) is a non-invasive method based on the principles of optical reflectometry (measurement of the degree of backscattering of light passing through transparent or translucent media). Limitations of the first devices of this type were associated with insufficient image quality of the details of the anterior chamber angle and the posterior parts of the lens, primarily due to the \"working\" level of the scanning wavelength (within 800 μm). Fundamentally new possibilities in the structural and functional assessment of the anterior segment of the eye are associated with the introduction into clinical practice of swept-source AS-OCT device - the CASIA2 anterior optical coherence tomograph (Tomey Corporation, Japan). Its high scanning speed (50 000 A-scans per second) with a wavelength of 1310 μm allows high-quality visualization by building a scan at a depth of 13 mm. The previous model (CASIA SS-1000, Tomey Corporation, Japan) supported scan depth of only 6 mm. This review summarizes the results of research on the clinical use of CASIA2 tomograph.</p>","PeriodicalId":23529,"journal":{"name":"Vestnik oftalmologii","volume":"140 2. Vyp. 2","pages":"190-195"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140912804","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01DOI: 10.17116/oftalma20241400315
A F Brovkina, N D Tsybikova
MicroRNAs (miRNAs) are short non-coding RNAs (18-25 nucleotides in length) that are important participants in the regulation of gene expression. In 2003, their active role in oncogenesis was demonstrated. In 2008, the first report on the isolation of miRNAs from uveal melanoma (UM) tissue was published. Four years later (2012), the presence of miRNAs in the plasma of patients with this category was shown. To date, changes in the expression level of 100 miRNAs in the plasma of cancer patients (with cancer of various localizations) out of the 2654 miRNAs described in mirbase.org have been proven. In the plasma of patients with UM, changes in the expression of only 13 miRNAs have been confirmed. As a rule, studies were conducted in patients at the stage of hematogenous metastasis of UM.
Purpose: This study analyzed the expression pattern of miRNA-223 and miRNA-126 in patients with localized choroidal melanoma (CM) taking into account biometric parameters in the absence of metastases.
Material and methods: Blood plasma of 84 patients with M0N0 CM aged 35-86 years (mean age 63.4±1.2 years) was investigated. The basis for the diagnosis of CM was the results of ophthalmological examination, optical coherence tomography, and ultrasound scanning. In all cases, the absence of metastases was proven (using computed tomography or magnetic resonance imaging). Control - plasma of 28 volunteers (mean age 62.9±1.42 years, age range 45-78 years), who did not have tumoral, autoimmune, or chronic inflammatory processes. The expression levels of miRNAs circulating in blood plasma were determined by real-time polymerase chain reaction.
Results: An increase in the expression levels of miRNA-223 and miRNA-126 in the plasma of all 84 patients with CM was confirmed compared to the control group. Features of the miRNA expression pattern that emerged with changes in the tumor's quantitative parameters were identified.
Conclusion: Evaluation of the levels of miRNA-223 and miRNA-126 in the blood plasma of patients with CM can be used in clinical practice to clarify the diagnosis of CM, as well as to predict the development of hematogenous metastases.
{"title":"[Epigenetic markers of choroidal melanoma].","authors":"A F Brovkina, N D Tsybikova","doi":"10.17116/oftalma20241400315","DOIUrl":"https://doi.org/10.17116/oftalma20241400315","url":null,"abstract":"<p><p>MicroRNAs (miRNAs) are short non-coding RNAs (18-25 nucleotides in length) that are important participants in the regulation of gene expression. In 2003, their active role in oncogenesis was demonstrated. In 2008, the first report on the isolation of miRNAs from uveal melanoma (UM) tissue was published. Four years later (2012), the presence of miRNAs in the plasma of patients with this category was shown. To date, changes in the expression level of 100 miRNAs in the plasma of cancer patients (with cancer of various localizations) out of the 2654 miRNAs described in mirbase.org have been proven. In the plasma of patients with UM, changes in the expression of only 13 miRNAs have been confirmed. As a rule, studies were conducted in patients at the stage of hematogenous metastasis of UM.</p><p><strong>Purpose: </strong>This study analyzed the expression pattern of miRNA-223 and miRNA-126 in patients with localized choroidal melanoma (CM) taking into account biometric parameters in the absence of metastases.</p><p><strong>Material and methods: </strong>Blood plasma of 84 patients with M<sub>0</sub>N<sub>0</sub> CM aged 35-86 years (mean age 63.4±1.2 years) was investigated. The basis for the diagnosis of CM was the results of ophthalmological examination, optical coherence tomography, and ultrasound scanning. In all cases, the absence of metastases was proven (using computed tomography or magnetic resonance imaging). Control - plasma of 28 volunteers (mean age 62.9±1.42 years, age range 45-78 years), who did not have tumoral, autoimmune, or chronic inflammatory processes. The expression levels of miRNAs circulating in blood plasma were determined by real-time polymerase chain reaction.</p><p><strong>Results: </strong>An increase in the expression levels of miRNA-223 and miRNA-126 in the plasma of all 84 patients with CM was confirmed compared to the control group. Features of the miRNA expression pattern that emerged with changes in the tumor's quantitative parameters were identified.</p><p><strong>Conclusion: </strong>Evaluation of the levels of miRNA-223 and miRNA-126 in the blood plasma of patients with CM can be used in clinical practice to clarify the diagnosis of CM, as well as to predict the development of hematogenous metastases.</p>","PeriodicalId":23529,"journal":{"name":"Vestnik oftalmologii","volume":"140 3","pages":"5-10"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141499072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01DOI: 10.17116/oftalma202414003151
N V Makashova, A E Vasillyeva, O Yu Kolosova
Purpose: This study investigates the effect of preoperative preparation with the three-component tear substitute Stillavit on the outcomes of glaucoma surgery in patients on long-term topical glaucoma therapy.
Material and methods: The study included 63 patients (63 eyes) with glaucoma, among them 30 (30 eyes) were women and 33 (33 eyes) were men. Group 1 consisted of 33 patients (33 eyes) receiving long-term topical antihypertensive therapy with preservatives and tear substitute Stillavit 3 times a day for 1 month as preoperative preparation. Group 2 included 30 patients (30 eyes) receiving similar antihypertensive therapy who were not prescribed preoperative medications. All patients underwent a comprehensive ophthalmological examination and computer tomography of the filtering blebs (FB) on Visante system (Carl Zeiss Meditec, Germany) before surgery, as well as 1 week, 1, 3, and 6 months after surgery.
Results: Mean intraocular pressure (IOP) elevation at 6 months postoperatively was significantly higher in the group that did not undergo preoperative preparation with a tear substitute, compared to the group of patients who received the tear substitute Stillavit preoperatively. According to anterior segment optical coherence tomography, a greater number of favorable diffuse FB were noted in the group that received the tear substitute Stillavit in preparation for surgery - 87.9%, while in group 2 (without preparation) - 66.7%. Odds ratio calculation between the two groups revealed that preoperative preparation with the tear substitute Stillavit reduced the odds of IOP elevation to 20 mm Hg or higher at 3 months postoperatively by more than 10 times.
Conclusion: The use of tear substitute Stillavit in preparation for anti-glaucoma surgery reduces the chances of IOP elevation in the early postoperative period by more than 10 times, which may indicate a reduction in the rate of FB scarring due to the beneficial effect of the drug's components on the precorneal tear film.
{"title":"[Three-component tear substitute as preoperative support in glaucoma surgery].","authors":"N V Makashova, A E Vasillyeva, O Yu Kolosova","doi":"10.17116/oftalma202414003151","DOIUrl":"https://doi.org/10.17116/oftalma202414003151","url":null,"abstract":"<p><strong>Purpose: </strong>This study investigates the effect of preoperative preparation with the three-component tear substitute Stillavit on the outcomes of glaucoma surgery in patients on long-term topical glaucoma therapy.</p><p><strong>Material and methods: </strong>The study included 63 patients (63 eyes) with glaucoma, among them 30 (30 eyes) were women and 33 (33 eyes) were men. Group 1 consisted of 33 patients (33 eyes) receiving long-term topical antihypertensive therapy with preservatives and tear substitute Stillavit 3 times a day for 1 month as preoperative preparation. Group 2 included 30 patients (30 eyes) receiving similar antihypertensive therapy who were not prescribed preoperative medications. All patients underwent a comprehensive ophthalmological examination and computer tomography of the filtering blebs (FB) on Visante system (Carl Zeiss Meditec, Germany) before surgery, as well as 1 week, 1, 3, and 6 months after surgery.</p><p><strong>Results: </strong>Mean intraocular pressure (IOP) elevation at 6 months postoperatively was significantly higher in the group that did not undergo preoperative preparation with a tear substitute, compared to the group of patients who received the tear substitute Stillavit preoperatively. According to anterior segment optical coherence tomography, a greater number of favorable diffuse FB were noted in the group that received the tear substitute Stillavit in preparation for surgery - 87.9%, while in group 2 (without preparation) - 66.7%. Odds ratio calculation between the two groups revealed that preoperative preparation with the tear substitute Stillavit reduced the odds of IOP elevation to 20 mm Hg or higher at 3 months postoperatively by more than 10 times.</p><p><strong>Conclusion: </strong>The use of tear substitute Stillavit in preparation for anti-glaucoma surgery reduces the chances of IOP elevation in the early postoperative period by more than 10 times, which may indicate a reduction in the rate of FB scarring due to the beneficial effect of the drug's components on the precorneal tear film.</p>","PeriodicalId":23529,"journal":{"name":"Vestnik oftalmologii","volume":"140 3","pages":"51-58"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141499127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01DOI: 10.17116/oftalma202414003182
N I Kurysheva, O Ye Rodionova, A L Pomerantsev, G A Sharova
This article reviews literature on the use of artificial intelligence (AI) for screening, diagnosis, monitoring and treatment of glaucoma. The first part of the review provides information how AI methods improve the effectiveness of glaucoma screening, presents the technologies using deep learning, including neural networks, for the analysis of big data obtained by methods of ocular imaging (fundus imaging, optical coherence tomography of the anterior and posterior eye segments, digital gonioscopy, ultrasound biomicroscopy, etc.), including a multimodal approach. The results found in the reviewed literature are contradictory, indicating that improvement of the AI models requires further research and a standardized approach. The use of neural networks for timely detection of glaucoma based on multimodal imaging will reduce the risk of blindness associated with glaucoma.
{"title":"[Application of artificial intelligence in glaucoma. Part 1. Neural networks and deep learning in glaucoma screening and diagnosis].","authors":"N I Kurysheva, O Ye Rodionova, A L Pomerantsev, G A Sharova","doi":"10.17116/oftalma202414003182","DOIUrl":"https://doi.org/10.17116/oftalma202414003182","url":null,"abstract":"<p><p>This article reviews literature on the use of artificial intelligence (AI) for screening, diagnosis, monitoring and treatment of glaucoma. The first part of the review provides information how AI methods improve the effectiveness of glaucoma screening, presents the technologies using deep learning, including neural networks, for the analysis of big data obtained by methods of ocular imaging (fundus imaging, optical coherence tomography of the anterior and posterior eye segments, digital gonioscopy, ultrasound biomicroscopy, etc.), including a multimodal approach. The results found in the reviewed literature are contradictory, indicating that improvement of the AI models requires further research and a standardized approach. The use of neural networks for timely detection of glaucoma based on multimodal imaging will reduce the risk of blindness associated with glaucoma.</p>","PeriodicalId":23529,"journal":{"name":"Vestnik oftalmologii","volume":"140 3","pages":"82-87"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141499068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01DOI: 10.17116/oftalma202414003170
N Yu Gorbunova, R A Yakovlev, N A Pozdeyeva, N O Mikhailov
Purpose: This study evaluates the effectiveness of implantation of extended depth of focus (EDOF) intraocular lenses (IOL) in patients with cataract and glaucoma.
Material and methods: The study included 13 patients (16 eyes) who underwent implantation of the Lentis Comfort EDOF IOL (Teleon Surgical BV, Netherlands). Standard phacoemulsification cataract surgery with IOL implantation was performed in a planned manner after the hypotensive surgery stage in two eyes; a combined procedure was performed in 14 cases. Uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), near visual acuity, and intraocular pressure (IOP) measured with a Maklakov tonometer were assessed preoperatively, on the first day, and 3-6 months after surgery. Computer perimetry using the 30-2 program and spatial contrast sensitivity (SCS) assessment were also performed preoperatively and at the same follow-up time points.
Results: On the first day after surgery, UCVA was 0.53±0.65, BCVA was 0.85±0.45. Near UCVA (at 40 cm) was 0.5±0.14 on the first day after surgery and 0.56±0.18 at 3-6 months. According to computer perimetry data, retinal light sensitivity values increased in all patients in the long-term (-3.1±2.9 dB). SCS values increased for objects of all sizes compared to preoperative values.
Conclusion: Implantation of EDOF IOL contributes to improved vision without reducing contrast sensitivity and retinal light sensitivity in patients with concomitant cataract and glaucoma.
{"title":"[First experience of implantation of extended depth of focus intraocular lenses in patients with glaucoma].","authors":"N Yu Gorbunova, R A Yakovlev, N A Pozdeyeva, N O Mikhailov","doi":"10.17116/oftalma202414003170","DOIUrl":"https://doi.org/10.17116/oftalma202414003170","url":null,"abstract":"<p><strong>Purpose: </strong>This study evaluates the effectiveness of implantation of extended depth of focus (EDOF) intraocular lenses (IOL) in patients with cataract and glaucoma.</p><p><strong>Material and methods: </strong>The study included 13 patients (16 eyes) who underwent implantation of the Lentis Comfort EDOF IOL (Teleon Surgical BV, Netherlands). Standard phacoemulsification cataract surgery with IOL implantation was performed in a planned manner after the hypotensive surgery stage in two eyes; a combined procedure was performed in 14 cases. Uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), near visual acuity, and intraocular pressure (IOP) measured with a Maklakov tonometer were assessed preoperatively, on the first day, and 3-6 months after surgery. Computer perimetry using the 30-2 program and spatial contrast sensitivity (SCS) assessment were also performed preoperatively and at the same follow-up time points.</p><p><strong>Results: </strong>On the first day after surgery, UCVA was 0.53±0.65, BCVA was 0.85±0.45. Near UCVA (at 40 cm) was 0.5±0.14 on the first day after surgery and 0.56±0.18 at 3-6 months. According to computer perimetry data, retinal light sensitivity values increased in all patients in the long-term (-3.1±2.9 dB). SCS values increased for objects of all sizes compared to preoperative values.</p><p><strong>Conclusion: </strong>Implantation of EDOF IOL contributes to improved vision without reducing contrast sensitivity and retinal light sensitivity in patients with concomitant cataract and glaucoma.</p>","PeriodicalId":23529,"journal":{"name":"Vestnik oftalmologii","volume":"140 3","pages":"70-74"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141499119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-01-01DOI: 10.17116/oftalma202414005135
O V Kolenko, L V Bushnina, I E Pashentsev, N V Pomytkina, E L Sorokin
Purpose: This study aimed to identify factors associated with the development of myopic maculopathy (MM) in patients with acquired myopia.
Material and methods: The study included a total of 135 patients (41 men, 94 women; 135 eyes) over 30 years old with acquired myopia and axial length (AL) of 26 mm. Forty-six patients had MM, while 89 (66%) had no macular changes. Optical coherence tomography angiography (OCT-A) and B-scan ultrasound of the eyes were performed to detect staphylomas of the posterior pole sclera. OCT was used to assess corneal stromal thickness and choroidal thickness. Corneal biomechanics were measured using the Corvis ST device, and ocular vessel hemodynamics were evaluated using color Doppler imaging. Binary logistic regression was employed, with a multivariable logistic model built for each of these potential risk factors, adjusted for sex, age, AL, and spherical equivalent (SE).
Results: Age, AL, SE, and extra-macular myopic changes were significantly associated with the presence of MM. Of the seven qualitative risk factors studied, the presence of extra-macular changes, staphyloma, and wide macular staphyloma localization were statistically significant. Among the quantitative factors, significant associations were found with the width and depth of staphyloma, the area of the ultrasound cross-section of staphyloma (W×D), choroidal thickness in all examined zones, all corneal stromal thickness parameters, corneal deformation amplitude (DA), curvature radius highest concavity (radius HC), and corneal peak distance (PD).
Conclusion: The statistically significant risk factors associated with MM were age, AL, SE, the presence and size of staphylomas, choroidal and corneal stromal thickness, as well as several parameters characterizing corneal biomechanical properties. The strongest associations with MM were found for corneal PD, staphyloma depth, and choroidal thickness in the nasal perifovea.
目的:本研究旨在确定后天性近视患者发生近视性黄斑病变(MM)的相关因素:研究共纳入 135 名年龄超过 30 岁的后天性近视患者(41 名男性,94 名女性;135 只眼睛),他们的轴长(AL)均为 26 毫米。46名患者患有黄斑病变,89名患者(66%)没有黄斑病变。为检测后极部巩膜葡萄状瘤,对患者的眼睛进行了光学相干断层血管造影(OCT-A)和 B 超扫描。光学相干断层扫描用于评估角膜基质厚度和脉络膜厚度。使用 Corvis ST 设备测量角膜生物力学,并使用彩色多普勒成像评估眼部血管血流动力学。采用二元逻辑回归法,针对每个潜在风险因素建立多变量逻辑模型,并对性别、年龄、AL和球面等值(SE)进行调整:结果:年龄、视力等效值、球面等效值和黄斑外近视变化与 MM 的存在有显著相关性。在所研究的七个定性风险因素中,黄斑外病变、葡萄胎瘤和宽黄斑葡萄胎瘤定位的存在具有统计学意义。在定量因素中,葡萄状瘤的宽度和深度、葡萄状瘤的超声截面面积(W×D)、所有检查区域的脉络膜厚度、所有角膜基质厚度参数、角膜变形幅度(DA)、曲率半径最高凹度(半径HC)和角膜峰值距离(PD)均有显著相关性:在统计学上,与MM相关的重要风险因素包括年龄、AL、SE、葡萄状瘤的存在和大小、脉络膜和角膜基质厚度,以及几个表征角膜生物力学特性的参数。角膜PD、葡萄状瘤深度和鼻眼周脉络膜厚度与MM的关联性最强。
{"title":"[Risk factors associated with myopic maculopathy in acquired myopia].","authors":"O V Kolenko, L V Bushnina, I E Pashentsev, N V Pomytkina, E L Sorokin","doi":"10.17116/oftalma202414005135","DOIUrl":"https://doi.org/10.17116/oftalma202414005135","url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to identify factors associated with the development of myopic maculopathy (MM) in patients with acquired myopia.</p><p><strong>Material and methods: </strong>The study included a total of 135 patients (41 men, 94 women; 135 eyes) over 30 years old with acquired myopia and axial length (AL) of 26 mm. Forty-six patients had MM, while 89 (66%) had no macular changes. Optical coherence tomography angiography (OCT-A) and B-scan ultrasound of the eyes were performed to detect staphylomas of the posterior pole sclera. OCT was used to assess corneal stromal thickness and choroidal thickness. Corneal biomechanics were measured using the Corvis ST device, and ocular vessel hemodynamics were evaluated using color Doppler imaging. Binary logistic regression was employed, with a multivariable logistic model built for each of these potential risk factors, adjusted for sex, age, AL, and spherical equivalent (SE).</p><p><strong>Results: </strong>Age, AL, SE, and extra-macular myopic changes were significantly associated with the presence of MM. Of the seven qualitative risk factors studied, the presence of extra-macular changes, staphyloma, and wide macular staphyloma localization were statistically significant. Among the quantitative factors, significant associations were found with the width and depth of staphyloma, the area of the ultrasound cross-section of staphyloma (W×D), choroidal thickness in all examined zones, all corneal stromal thickness parameters, corneal deformation amplitude (DA), curvature radius highest concavity (radius HC), and corneal peak distance (PD).</p><p><strong>Conclusion: </strong>The statistically significant risk factors associated with MM were age, AL, SE, the presence and size of staphylomas, choroidal and corneal stromal thickness, as well as several parameters characterizing corneal biomechanical properties. The strongest associations with MM were found for corneal PD, staphyloma depth, and choroidal thickness in the nasal perifovea.</p>","PeriodicalId":23529,"journal":{"name":"Vestnik oftalmologii","volume":"140 5","pages":"35-45"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142681854","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}